As we await the results of this high-stakes game, scientists ponder potential outcomes. Will the smallpox vaccine prove effective against monkeypox? Could this alternative use of the vaccine revolutionize our approach to combating infectious diseases? Only time will tell. In the meantime, let’s dive deeper into the research behind the vaccine and see why it has caught the attention of the Biden administration. Together, we can unravel the mysteries of this unprecedented risk and discover how science is adapting to tackle new challenges and keep us safe.
The Biden administration is hoping — potentially to the tune of $3.9 billion — that a vaccine designed to prevent smallpox can work to save lives against the monkeypox outbreak, sending it out without human trials.